Our results indicated most DNA methylation regulators (DNMT1, MBD3, UHRF1, and TDG) with amplificated CNV demonstrated markedly higher expression in GBM, which revealed that the alterations of CNV could be an important element resulting in perturbations on the DNA methylation regulators expression in glioma. This evidence concerns the gene UHRF1 and glioblastoma.